GSK Investigational Site

Málaga, Andalusia 29004

0 studies enrolling now · 2 studies all time

What they study most

Infections, Rotavirus, Respiratory Syncytial Virus Infections, Rotavirus Vaccines

Studies at this site

• Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants — Completed
• Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks — Completed